Akhil Varshney

Akhil Varshney

Auto-generated profile, based on publicly available information

Akhil Varshney

Applied Molecular Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2017 in Nature Medicine
Verified
Journal Article
Open access
PDF file
NKNagaraj Kerur
Nagaraj Kerur
SFShinichi Fukuda
Shinichi Fukuda
DBDaipayan Banerjee
Daipayan Banerjee
YKYounghee Kim
Younghee Kim
DFDongxu Fu
Dongxu Fu
JAJayakrishna Ambati
Jayakrishna Ambati
Degeneration of the retinal pigment epithelium is a hallmark of geographic atrophy, a type of age-related macular degeneration. Kerur et al. show that this degeneration results from a multistep pathway in which mitochondrial dysfunction in RPE cells, triggered by accumulation of Alu RNA, leads to activation of the noncanonical inflammasome via a cGAS–STING–IRF3 signaling axis. Geographic atrophy is a blinding form of age-related macular degeneration characterized by retinal pigmented epithelium (RPE) death; the RPE also exhibits DICER1 deficiency, resultant accumulation of endogenous Alu-retroelement RNA, and NLRP3-inflammasome activation. How the inflammasome is activated in this untreatable disease is largely unknown. Here we demonstrate that RPE degeneration in human-cell-culture and mouse models is driven by a noncanonical-inflammasome pathway that activates caspase-4 (caspase-11 in mice) and caspase-1, and requires cyclic GMP-AMP synthase (cGAS)-dependent interferon-β production and gasdermin D–dependent interleukin-18 secretion. Decreased DICER1 levels or Alu-RNA accumulation triggers cytosolic escape of mitochondrial DNA, which engages cGAS. Moreover, caspase-4, gasdermin D, interferon-β, and cGAS levels were elevated in the RPE in human eyes with geographic atrophy. Collectively, these data highlight an unexpected role of cGAS in responding to mobile-element transcripts, reveal cGAS-driven interferon signaling as a conduit for mitochondrial-damage-induced inflammasome activation, expand the immune-sensing repertoire of cGAS and caspase-4 to noninfectious human disease, and identify new potential targets for treatment of a major cause of blindness.

5 December 2014 in Cell Biochemistry and Function
Verified
Journal Article
Closed access
PDF file
BSBaby Santosh
Baby Santosh
AVAkhil Varshney
Akhil Varshney
PYPramod Kumar Yadava
Pramod Kumar Yadava

7 October 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MAMeenakshi Ambati
Meenakshi Ambati
IAIvana Apicella
Ivana Apicella
SHAOBIN WANGSHAOBIN WANG
SHAOBIN WANG
SNSiddharth Narendran
Siddharth Narendran
HLHannah Leung
Hannah Leung
BGBradley D Gelfand
Bradley D Gelfand
The atrophic form of age-related macular degeneration (dry AMD) affects nearly 200 million people worldwide. There is no Food and Drug Administration (FDA)-approved therapy for this disease, which is the leading cause of irreversible blindness among people over 50 y of age. Vision loss in dry AMD results from degeneration of the retinal pigmented epithelium (RPE). RPE cell death is driven in part by accumulation of Alu RNAs, which are noncoding transcripts of a human retrotransposon. Alu RNA induces RPE degeneration by activating the NLRP3-ASC inflammasome. We report that fluoxetine, an FDA-approved drug for treating clinical depression, binds NLRP3 in silico, in vitro, and in vivo and inhibits activation of the NLRP3-ASC inflammasome and inflammatory cytokine release in RPE cells and macrophages, two critical cell types in dry AMD. We also demonstrate that fluoxetine, unlike several other antidepressant drugs, reduces Alu RNA–induced RPE degeneration in mice. Finally, by analyzing two health insurance databases comprising more than 100 million Americans, we report a reduced hazard of developing dry AMD among patients with depression who were treated with fluoxetine. Collectively, these studies identify fluoxetine as a potential drug-repurposing candidate for dry AMD. Significance Dry age-related macular degeneration (AMD) affects the vision of millions of people worldwide. There is currently no Food and Drug Administration–approved treatment for dry AMD. The inflammasome components NLRP3 and ASC have been implicated in the pathogenesis of dry AMD. We report that fluoxetine, which is approved for the treatment of clinical depression, directly binds the NLRP3 protein and prevents NLRP3-ASC inflammasome assembly and activation. Fluoxetine prevents the degeneration of retinal pigmented epithelium cells in an animal model of dry AMD. We also present evidence from a big data analysis of health insurance databases that fluoxetine use is associated with reduced risk of developing dry AMD. These studies identify a potential repurposing candidate for a prevalent cause of blindness.

9 February 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SFShinichi Fukuda
Shinichi Fukuda
AVAkhil Varshney
Akhil Varshney
BFBenjamin J. Fowler
Benjamin J. Fowler
SHAOBIN WANGSHAOBIN WANG
SHAOBIN WANG
SNSiddharth Narendran
Siddharth Narendran
JAJayakrishna Ambati
Jayakrishna Ambati
Significance: Alu elements, comprising more than 10% of the human genome, propagate via retrotransposition. This genomic expansion requires enzymatic activity of L1 that reverse transcribes Alu RNA into Alu cDNA in the nucleus. We report Alu also undergoes L1-mediated reverse transcription via self-priming in the cytoplasm independent of retrotransposition, providing evidence of human DNA synthesis in this cellular compartment. This newly discovered shunt molecule in the Alu replication cycle also induces death of the retinal pigmented epithelium, a hallmark of atrophic age-related macular degeneration. A Big Data Archeology analysis of multiple health insurance databases reveals that use of FDA-approved nucleoside reverse transcriptase inhibitors is associated with protection against macular degeneration, identifying a repurposing candidate for this blinding disease.

1 February 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
RJRishi Kumar Jaiswal
Rishi Kumar Jaiswal
AVAkhil Kumar Varshney
Akhil Kumar Varshney
PYPramod Kumar Yadava
Pramod Kumar Yadava

1 March 2019 in Life Sciences
Verified
Journal Article
Closed access
SYSuresh Singh Yadav
Suresh Singh Yadav
MKManoj Kumar
Manoj Kumar
AVAkhil Varshney
Akhil Varshney
PYPramod Kumar Yadava
Pramod Kumar Yadava